Alterity Therapeutics Ltd
ASX:ATH

Watchlist Manager
Alterity Therapeutics Ltd Logo
Alterity Therapeutics Ltd
ASX:ATH
Watchlist
Price: 0.009 AUD 12.5%
Market Cap: 97.9m AUD

Intrinsic Value

ATH doesn't have a meaningful market cap.

The intrinsic value of one ATH stock under the Base Case scenario is 0.045 AUD. Compared to the current market price of 0.009 AUD, Alterity Therapeutics Ltd is Undervalued by 80%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ATH Intrinsic Value
0.045 AUD
Undervaluation 80%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Alterity Therapeutics Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about ATH?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ATH valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Alterity Therapeutics Ltd.

Explain Valuation
Compare ATH to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ATH?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Alterity Therapeutics Ltd

Current Assets 45.9m
Cash & Short-Term Investments 33.2m
Receivables 3.9m
Other Current Assets 8.8m
Non-Current Assets 155.2k
PP&E 155.2k
Current Liabilities 3.5m
Accounts Payable 2.6m
Other Current Liabilities 959.2k
Non-Current Liabilities 88.6k
Long-Term Debt 88.6k
Efficiency

Free Cash Flow Analysis
Alterity Therapeutics Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Alterity Therapeutics Ltd

Revenue
446.3k AUD
Operating Expenses
-14.7m AUD
Operating Income
-14.2m AUD
Other Expenses
2.1m AUD
Net Income
-12.1m AUD
Fundamental Scores

ATH Profitability Score
Profitability Due Diligence

Alterity Therapeutics Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

22/100
Profitability
Score

Alterity Therapeutics Ltd's profitability score is 22/100. The higher the profitability score, the more profitable the company is.

ATH Solvency Score
Solvency Due Diligence

Alterity Therapeutics Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

Alterity Therapeutics Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ATH Price Targets Summary
Alterity Therapeutics Ltd

There are no price targets for ATH.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Alterity Therapeutics Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ATH is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one ATH stock?

The intrinsic value of one ATH stock under the Base Case scenario is 0.045 AUD.

Is ATH stock undervalued or overvalued?

Compared to the current market price of 0.009 AUD, Alterity Therapeutics Ltd is Undervalued by 80%.

Back to Top